DUBLIN, Mar. 05, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/5sqnn3/global_rising) has announced the addition of the "Global Rising Stars Outlook 2015" report to their offering. Innovative Therapies for treating diseases are being sought after with fresh vigor as new targets , approaches and biology is discovered. One field which is poised to bring a paradigm change in the way diseases are treated in the next decades is the Stem cell therapy/Regenerative Medicine space. The number of companies and products in the clinic have reached a critical mass warranting a close watch for those interested in keeping pace with the development of new medicines. The Regenerative medicine Universe is large and new companies are being added to it rapidly. As a result we have used some filters to select a few names for a detailed coverage in our Outlook this year. Key Criteria for Our Selection are: - Uniqueness of the Technology platform and the ability to scale up commercially in case of positive outcome of products in the pipeline - Pipeline and clinical data analysis - Marketed product and commercial tie up. Robustness of the Management, financial and business model. Key Topics Covered: Part 1- Rising Stars in Regenerative Medicine and … Continue reading →

Overcoming Knee Replacement Surgery Faster Using Amniotic Tissue-Enhanced Stem Cell Therapy Dr. McKenna discusses how the addition of a patient's own bone marrow stem cells combined with AlphaGEMS amniotic tissue product helps patients recover faster from a total knee replacement ... By: Riordan-McKenna Institute … Continue reading →

Knee arthritis one year after stem cell therapy by Harry Adelson, N.D. Frank describes his outcome one year after stem cell therapy for his arthritic knee by Harry Adelson, N.D. http://www.docereclinics.com. By: Harry Adelson, N.D. … Continue reading →

stem cell therapy helps avoiding knee surgery Meet John Tucker, he suffered from Osteoarthritis in his knee. Watch our live video to hear John's experience with Stem Cells! RMG is also proud to announce we are offering at 100% Knee Guarantee! By: iManifestart … Continue reading →

Stem Cell Therapy in Osteo Arthritis Knee stem cell india, stem cell therapy india, stem cell in india, stem cell therapy in india, india stem cell, india stem cell therapy, Osteo Arthritis Knee. By: Stem Cell India … Continue reading →

Patient claims a 100 percent recovery after having stem cell treatment done on her knee http://www.rejuvmedical.com/pages/stemcelltreatments This runner and active mom, claims she experienced a 100% recovery after having Platelet Rich Plasma and... By: Rejuv Medical … Continue reading →

Southlake, Texas (PRWEB) March 05, 2015 RMI specializes in Stemnexa non-surgical treatment of acute and chronic orthopedic conditions such as meniscal tears, ACL injuries, rotator cuff injuries, runners knee, tennis elbow, and joint pain due to degenerative conditions like osteoarthritis. Stemnexa may also be administered during orthopedic surgeries to promote better post-surgical outcomes. Stemnexa combines the latest, patented scientific advances in nearly pain-free bone marrow harvesting with two complimentary cellular technologies: Bone Marrow Aspirate Concentrate (BMAC) and *AlphaGEMS amniotic tissue product. BMAC contains a patients own mesenchymal stem cells (MSC,) hematopoietic stem cells (CD34+), growth factors and other progenitor cells. AlphaGEMS is composed of collagens and other structural proteins, which provide a biologic matrix that supports angiogenesis, tissue growth and new collagen during tissue regeneration and repair. *AlphaGEMS product is harvested from donated amniotic sac tissue after normal healthy births. For more information about AlphaGEMS, please visit: http://www.rmiclinic.com/non-surgical-stem-cell-injections-joint-pain/stemnexa-protocol/ Find out more about RMI in the February edition of Society Life Magazine. Riordan-McKenna Institute Riordan Medical Institute 801 E. Southlake Blvd. Southlake, Texas 76092 Tel: (817) 776-8155 Toll Free: (877) 899-7836 Fax: (817) 776-8154 See the original post here: Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House … Continue reading →

Drug used to treat limb disorder Mumbai, March 4: Stempeutics Research has received a process patent from the United States Patent and Trademarks Office for its novel stem cell-based drug Stempeucel. The company is part of the Manipal Education and Medical Group and drugmaker Cipla entered into a joint alliance with it in 2009. The drug will initially be used for the treatment of Critical Limb Ischemia (CLI), the companies said in a joint note, adding that the treatment option directly addresses the root cause of the disease, unlike others that treat the symptoms and not the disease. CLI is a progressive form of peripheral arterial disease that blocks arteries in the lower extremities of the body, resulting in reduced blood flow. It is a debilitating disease which affects patients with severe pain in the feet or toes, besides the development of sores and wounds, the note said. If left untreated, patients may have to undergo amputation of the affected limb, it added. Stempeutics has also submitted its applications to the regulatory Drug Controller General of India (DCGI) to obtain marketing authorisation for Stempeucel. The availability of the product in the local market is subject to DCGI approvals. Go here … Continue reading →